StockData
60 Degrees Pharmaceuticals, Inc. logo

60 Degrees Pharmaceuticals, Inc. (SXTP) income statement

SXTPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTPW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 8/3064% below fair value
$0.47−0.03 (-6.36%)

Close on Nov 20, 2026Market cap $1.65MP/E –Yield –

60 Degrees Pharmaceuticals, Inc. financial ratios

See a number that looks wrong?